GGrantIndex
← Leaderboards

Robert H Weiss

University Of California Davis

$3,328,356
Attributed
$3,328,356
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $663.4K · FY200918
$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$3,328,356 · 5

By mechanism

R01$2,875,981 · 3
R21$296,875 · 1
R03$155,500 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Davis

Same institution · by research overlap

Others in their field

Top investigators on “Metabolic

Research focus

MetabolicBaseUrinaryTechnologyResearch StudyRenal CarcinomaMetabolic PathwayMetabolomicsStagingPatternKidneyLeadKidney DiseasesClinicDetectionPrimary Health CareScientistTreatment ProtocolsPathway InteractionsPathway AnalysisGleanGrantInstitutionUrine

Grant awards (14)

A Metabolomic Approach to Discovering Markers for ADPKD Progression$210,884
R01 · FY2018 · DK · contact PI
A Metabolomic Approach to Discovering Markers for ADPKD Progression$210,881
R01 · FY2017 · DK · contact PI
A Metabolomic Approach to Discovering Markers for ADPKD Progression$218,522
R01 · FY2016 · DK · contact PI
The addition of fish oil to sorafenib may prevent kidney cancer metastasis$78,000
R03 · FY2015 · CA · contact PI
The addition of fish oil to sorafenib may prevent kidney cancer metastasis$77,500
R03 · FY2014 · CA · contact PI
Metabolomic discovery and validation of urinary biomarkers for kidney cancer$291,367
R01 · FY2013 · CA · contact PI
Metabolomic discovery and validation of urinary biomarkers for kidney cancer$309,890
R01 · FY2012 · CA · contact PI
Metabolomic discovery and validation of urinary biomarkers for kidney cancer$308,622
R01 · FY2011 · CA · contact PI
A Metabolomic Approach to Discovering Biomarkers for ADPKD$345,928
R01 · FY2010 · DK · contact PI
Metabolomic discovery and validation of urinary biomarkers for kidney cancer$317,475
R01 · FY2010 · CA · contact PI
A Metabolomic Approach to Discovering Biomarkers for ADPKD$350,000
R01 · FY2009 · DK · contact PI
Metabolomic discovery and validation of urinary biomarkers for kidney cancer$312,412
R01 · FY2009 · CA · contact PI
Cyclin Kinase Inhibitors as Molecular Targets for Cancer$148,500
R21 · FY2003 · CA
Cyclin Kinase Inhibitors as Molecular Targets for Cancer$148,375
R21 · FY2002 · CA